|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07C 311/46 | |
| A61K 31/18 |
| (11) | Number of the document | 3022175 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14748056.0 |
| Date of filing the European patent application | 2014-07-18 | |
| (97) | Date of publication of the European application | 2016-05-25 |
| (45) | Date of publication and mention of the grant of the patent | 2017-11-08 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2014/047265 |
| Date | 2014-07-18 |
| (87) | Number | WO 2015/010065 |
| Date | 2015-01-22 |
| (30) | Number | Date | Country code |
| 201361856146 P | 2013-07-19 | US |
| (72) |
HADIDA-RUAH, Sara Sabina, US
ANDERSON, Corey, US
TERMIN, Andreas P., US
BEAR, Brian Richard, US
ARUMUGAM, Vijayalaksmi, US
KRENITSKY, Paul, US
JOHNSON, James Philip, US
|
| (73) |
Vertex Pharmaceuticals Incorporated,
50 Northern Avenue, 15th Floor, Boston, MA 02210,
US
|
| (54) | SULFONAMIDES AS MODULATORS OF SODIUM CHANNELS |
| SULFONAMIDES AS MODULATORS OF SODIUM CHANNELS |